TREA

76373789 - IPSOGEN

Follow

Information

  • Trademark
  • 76373789
  • Serial Number
    76373789
  • Registration Number
    2958962
  • Filing Date
    February 20, 2002
    22 years ago
  • Registration Date
    June 07, 2005
    19 years ago
  • Transaction Date
    June 07, 2024
    3 months ago
  • Status Date
    December 15, 2015
    8 years ago
  • Published for Opposition Date
    March 15, 2005
    19 years ago
  • Renewal Date
    June 07, 2015
    9 years ago
  • Location Date
    December 15, 2015
    8 years ago
  • Status Code
    800
  • Current Location
    TMEG LAW OFFICE 105
    Employee Name
    CASE, LEIGH CAROLINE
  • Attorney Docket Number
    02-180T
    Attorney Name
    William B. Slate
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
1
Mark Identification
IPSOGEN
Case File Statements
  • GS0091: [ Information processing devices, namely, computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information ]
  • GS0051: Biological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS, cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcinosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma, centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastroesophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eye metastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastrinoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, head and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-grade lymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer, meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma, orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarian peritoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic leukemia, prophylactic mastectomy, prostate cancer, prostatic intraepithelial neoplasia, PIN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone, sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-cell lymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia, Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome ]
Case File Event Statements
  • 2/21/2003 - 21 years ago
    9 - LETTER OF SUSPENSION MAILED Type: CNSL
  • 3/15/2002 - 22 years ago
    1 - PAPER RECEIVED Type: MAIL
  • 3/15/2002 - 22 years ago
    2 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/15/2002 - 22 years ago
    3 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 6/14/2002 - 22 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/17/2002 - 22 years ago
    6 - UNRESPONSIVE/DUPLICATE PAPER RECEIVED Type: UNPR
  • 6/19/2002 - 22 years ago
    5 - NON-FINAL ACTION MAILED Type: CNRT
  • 12/13/2002 - 21 years ago
    7 - PAPER RECEIVED Type: MAIL
  • 12/13/2002 - 21 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/12/2004 - 19 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/13/2003 - 21 years ago
    10 - CASE FILE IN TICRS Type: CFIT
  • 10/23/2003 - 20 years ago
    11 - NON-FINAL ACTION MAILED Type: CNRT
  • 4/26/2004 - 20 years ago
    12 - PAPER RECEIVED Type: MAIL
  • 4/26/2004 - 20 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/26/2004 - 20 years ago
    14 - Sec. 1(B) CLAIM DELETED Type: 1.BD
  • 6/4/2004 - 20 years ago
    15 - NON-FINAL ACTION MAILED Type: CNRT
  • 9/22/2004 - 19 years ago
    16 - PAPER RECEIVED Type: MAIL
  • 9/22/2004 - 19 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/7/2004 - 19 years ago
    18 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 3/15/2005 - 19 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/7/2005 - 19 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/14/2011 - 13 years ago
    26 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 7/14/2011 - 13 years ago
    27 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 7/14/2011 - 13 years ago
    28 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 10/7/2015 - 8 years ago
    29 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/19/2004 - 19 years ago
    20 - ASSIGNED TO LIE Type: ALIE
  • 10/21/2004 - 19 years ago
    21 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/23/2005 - 19 years ago
    22 - NOTICE OF PUBLICATION Type: NPUB
  • 6/2/2011 - 13 years ago
    25 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 10/19/2015 - 8 years ago
    30 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 12/15/2015 - 8 years ago
    31 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 12/15/2015 - 8 years ago
    32 - REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED Type: 8PRT
  • 12/15/2015 - 8 years ago
    33 - REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 Type: 9G8P
  • 12/15/2015 - 8 years ago
    34 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 12/15/2015 - 8 years ago
    35 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8
  • 9/24/2020 - 3 years ago
    36 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/7/2024 - 3 months ago
    37 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2